Advisor Group’s Halozyme HALO Stock Holding History
Bought
Maintained
Sold
Other funds holding HALO
BG
TS
SCM
Advisor Group's HALO Position: Q4 2019 in Review
Advisor Group reduced its Halozyme (HALO) stake by 3.6% in Q4 2019, selling an estimated $2.35K and leaving 3,672 shares worth $65K. The position accounts for ﹤0.01% of the portfolio, ranked #3235.
Advisor Group first reported a position in HALO in Q2 2016 and has held it in 15 quarters since. The position peaked at $82K in Q3 2018. 224 funds tracked by Wall St. Rank hold HALO as of Q4 2019.
- Advisor Group held 3,672 shares of Halozyme worth $65K as of Q4 2019.
- Advisor Group sold 136 Halozyme shares in Q4 2019, an estimated $2.35K.
- Halozyme made up ﹤0.01% of Advisor Group's portfolio in Q4 2019, its #3235 holding.
- Advisor Group first reported a position in Halozyme in Q2 2016 and has held it in 15 quarters since.
- Advisor Group's Halozyme position peaked at $82K in Q3 2018.
- 224 funds tracked by Wall St. Rank held Halozyme as of Q4 2019.
Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.